Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset.

Fontana RJ, Hayashi PH, Gu J, Reddy KR, Barnhart H, Watkins PB, Serrano J, Lee WM, Chalasani N, Stolz A, Davern T, Talwakar JA; DILIN Network..

Gastroenterology. 2014 Jul;147(1):96-108.e4. doi: 10.1053/j.gastro.2014.03.045. Epub 2014 Mar 27.

2.

Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.

Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy KR, Watkins PB, Navarro V, Barnhart H, Gu J, Serrano J; United States Drug Induced Liver Injury Network..

Gastroenterology. 2015 Jun;148(7):1340-52.e7. doi: 10.1053/j.gastro.2015.03.006. Epub 2015 Mar 6.

3.

Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study.

Molleston JP, Fontana RJ, Lopez MJ, Kleiner DE, Gu J, Chalasani N; Drug-Induced Liver Injury Network..

J Pediatr Gastroenterol Nutr. 2011 Aug;53(2):182-9. doi: 10.1097/MPG.0b013e31821d6cfd.

4.

Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury.

Fontana RJ, Hayashi PH, Barnhart H, Kleiner DE, Reddy KR, Chalasani N, Lee WM, Stolz A, Phillips T, Serrano J, Watkins PB; DILIN Investigators..

Am J Gastroenterol. 2015 Oct;110(10):1450-9. doi: 10.1038/ajg.2015.283. Epub 2015 Sep 8.

5.

Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.

Robles-Diaz M, Lucena MI, Kaplowitz N, Stephens C, Medina-Cáliz I, González-Jimenez A, Ulzurrun E, Gonzalez AF, Fernandez MC, Romero-Gómez M, Jimenez-Perez M, Bruguera M, Prieto M, Bessone F, Hernandez N, Arrese M, Andrade RJ; Spanish DILI Registry.; SLatinDILI Network.; Safer and Faster Evidence-based Translation Consortium..

Gastroenterology. 2014 Jul;147(1):109-118.e5. doi: 10.1053/j.gastro.2014.03.050. Epub 2014 Apr 1.

PMID:
24704526
6.

Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.

Björnsson ES, Bergmann OM, Björnsson HK, Kvaran RB, Olafsson S.

Gastroenterology. 2013 Jun;144(7):1419-25, 1425.e1-3; quiz e19-20. doi: 10.1053/j.gastro.2013.02.006. Epub 2013 Feb 16.

PMID:
23419359
7.

Drug-induced liver injury.

Leise MD, Poterucha JJ, Talwalkar JA.

Mayo Clin Proc. 2014 Jan;89(1):95-106. doi: 10.1016/j.mayocp.2013.09.016. Review.

PMID:
24388027
8.

Drug-induced liver injury caused by intravenously administered medications: the Drug-induced Liver Injury Network experience.

Ghabril M, Fontana R, Rockey D, Jiezhun G, Chalasani N.

J Clin Gastroenterol. 2013 Jul;47(6):553-8. doi: 10.1097/MCG.0b013e318276bf00.

9.

Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.

Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J; Drug Induced Liver Injury Network (DILIN)..

Gastroenterology. 2008 Dec;135(6):1924-34, 1934.e1-4. doi: 10.1053/j.gastro.2008.09.011. Epub 2008 Sep 17.

10.

Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury.

Devarbhavi H, Singh R, Patil M, Sheth K, Adarsh CK, Balaraju G.

J Gastroenterol Hepatol. 2013 Jan;28(1):161-7. doi: 10.1111/j.1440-1746.2012.07279.x.

PMID:
23020522
11.

The incidence, presentation, outcomes, risk of mortality and economic data of drug-induced liver injury from a national database in Thailand: a population-base study.

Sobhonslidsuk A, Poovorawan K, Soonthornworasiri N, Pan-Ngum W, Phaosawasdi K.

BMC Gastroenterol. 2016 Oct 28;16(1):135.

12.

Model for end-stage liver disease score as a predictor of short-term outcome in patients with drug-induced liver injury.

Jeong R, Lee YS, Sohn C, Jeon J, Ahn S, Lim KS.

Scand J Gastroenterol. 2015 Apr;50(4):439-46. doi: 10.3109/00365521.2014.958094. Epub 2015 Feb 1.

PMID:
25639449
13.

Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.

Lo Re V 3rd, Haynes K, Forde KA, Goldberg DS, Lewis JD, Carbonari DM, Leidl KB, Reddy KR, Nezamzadeh MS, Roy J, Sha D, Marks AR, De Boer J, Schneider JL, Strom BL, Corley DA.

Clin Gastroenterol Hepatol. 2015 Dec;13(13):2360-8. doi: 10.1016/j.cgh.2015.06.020. Epub 2015 Jun 27.

14.

Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury.

Medina-Caliz I, Robles-Diaz M, Garcia-Muñoz B, Stephens C, Ortega-Alonso A, Garcia-Cortes M, González-Jimenez A, Sanabria-Cabrera JA, Moreno I, Fernandez MC, Romero-Gomez M, Navarro JM, Barriocanal AM, Montane E, Hallal H, Blanco S, Soriano G, Roman EM, Gómez-Dominguez E, Castiella A, Zapata EM, Jimenez-Perez M, Moreno JM, Aldea-Perona A, Hernández-Guerra M, Prieto M, Zoubek ME, Kaplowitz N, Lucena MI, Andrade RJ; Spanish DILI registry..

J Hepatol. 2016 Sep;65(3):532-42. doi: 10.1016/j.jhep.2016.05.003. Epub 2016 May 13.

PMID:
27184533
15.

Risk of drug-induced liver injury from tumor necrosis factor antagonists.

Björnsson ES, Gunnarsson BI, Gröndal G, Jonasson JG, Einarsdottir R, Ludviksson BR, Gudbjörnsson B, Olafsson S.

Clin Gastroenterol Hepatol. 2015 Mar;13(3):602-8. doi: 10.1016/j.cgh.2014.07.062. Epub 2014 Aug 15.

PMID:
25131534
16.

An update on drug induced liver injury.

Rangnekar AS, Fontana RJ.

Minerva Gastroenterol Dietol. 2011 Jun;57(2):213-29. Review.

PMID:
21587150
17.

Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States?

Vuppalanchi R, Liangpunsakul S, Chalasani N.

Am J Gastroenterol. 2007 Mar;102(3):558-62; quiz 693.

PMID:
17156142
18.

Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation.

Sembera S, Lammert C, Talwalkar JA, Sanderson SO, Poterucha JJ, Hay JE, Wiesner RH, Gores GJ, Rosen CB, Heimbach JK, Charlton MR.

Liver Transpl. 2012 Jul;18(7):803-10. doi: 10.1002/lt.23424.

19.

Idiosyncratic drug-induced liver injury: an update on the 2007 overview.

Hussaini SH, Farrington EA.

Expert Opin Drug Saf. 2014 Jan;13(1):67-81. doi: 10.1517/14740338.2013.828032. Epub 2013 Sep 27. Review.

PMID:
24073714
20.

[Prevalence and risk factors of drug induced liver disease: a survey based study in pharmacies].

Jüngst C, Gräber S, Klahn D, Wedemeyer H, Lammert F.

Z Gastroenterol. 2016 Feb;54(2):131-8. doi: 10.1055/s-0041-104024. Epub 2016 Feb 8. German.

PMID:
26854832

Supplemental Content

Support Center